Methamphetamine-Related Disorders

被引:25
|
作者
Gouzoulis-Mayfrank, Euphrosyne [1 ]
Haertel-Petri, Roland [2 ]
Hamdorf, Willem [3 ]
Havemann-Reinecke, Ursula [4 ]
Muehlig, Stephan [5 ]
Wodarz, Norbert [6 ]
机构
[1] Rhineland Reg Council, LVR, Klin Koln, Landschaftsverband Rheinland, Cologne, Germany
[2] Psychotherapeut Practice Bayreuth, Bayreuth, Germany
[3] Allgemeine Hosp Gesell, Klin Mecklenburg, Mecklenburg, Germany
[4] Univ Med Ctr Gottingen, Gottingen, Germany
[5] Tech Univ Chemnitz, Chemnitz, Germany
[6] Univ Hosp Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2017年 / 114卷 / 26期
关键词
PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; DEPENDENT INDIVIDUALS; RESIDENTIAL-TREATMENT; DEPRESSION; IMIPRAMINE; BUPROPION; EXERCISE; BIPOLAR; USERS;
D O I
10.3238/arztebl.2017.0455
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Methamphetamine is considered more dangerous than other stimulants because of its acute complications, long-term neurotoxicity, and potential for drug dependence. Until now, there have been no evidence-based guidelines for the treatment of methamphetamine-related disorders, either in Germany or abroad. Methods: A systematic literature search was performed on the treatment of methamphetamine-related disorders. Based on this literature review, a multi-disciplinary expert panel developed recommendations using the nominal group technique. Results: The evidence base for the treatment of methamphetamine-related disorders is sparse. The efficacy of psychotherapeutic techniques such as cognitive behavioral therapy and contingency management and the efficacy of complex, disorder-specific treatment programs have been proven in ran domized controlled trials, but it remains unclear which method is best. Persons carrying a diagnosis of substance abuse should be offered psychotherapy. Structured exercise programs, whether self-directed or professionally led, can improve addiction-specific endpoints as well as comorbid disorders and should, therefore, be offered as well. Pharmacotherapy has shown little to no effect in relatively low-quality clinical trials with low case numbers and high dropout rates, and therefore only a few weak recommendations were made. These include tranquilizers for the short-term treatment of agitation and atypical antipsychotics if necessary. Attempts to substitute other substances, such as methylphenidate or dexamphetamine, for methamphetamine have not yielded any robust evidence to date. Sertraline should not be administered due to serious adverse events. Conclusion: Many of the recommendations in the guideline are made with a weak grade of recommendation because of the poor evidence base and the modest size of the reported therapeutic effects. In acute situations, symptomoriented treatment is recommended. Psychotherapy and exercise should be offered as well.
引用
收藏
页码:455 / +
页数:10
相关论文
共 50 条
  • [1] Candidate gene analysis of methamphetamine-related disorders
    Ujike, H
    Inada, T
    Harano, M
    Komiyama, T
    Yamada, M
    Sekine, Y
    Iwata, N
    Iyo, M
    Sora, I
    Ozaki, N
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S24 - S25
  • [2] Methamphetamine-related burns in the cornbelt
    Burke, Bridget A.
    Lewis, Robert W., II
    Latenser, Barbara A.
    Chung, Joseph Y.
    Willoughby, Clark
    Ealey, G. Patrick
    Wibbenmeyer, Lucy A.
    JOURNAL OF BURN CARE & RESEARCH, 2008, 29 (04): : 574 - 579
  • [3] Methamphetamine-related brainstem haemorrhage
    Chiu, Zelia K.
    Bennett, Iwan E.
    Chan, Patrick
    Rosenfeld, Jeffrey V.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 32 : 137 - 139
  • [4] Methamphetamine-related cardiovascular diseases
    Schwarzbach, Valentin
    Lenk, Karsten
    Laufs, Ulrich
    ESC HEART FAILURE, 2020, 7 (02): : 407 - 414
  • [5] Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders
    McKetin, Rebecca
    Baker, Amanda L.
    Dawe, Sharon
    Voce, Alexandra
    Lubman, Dan I.
    PSYCHIATRY RESEARCH, 2017, 251 : 349 - 354
  • [6] Integrated Care for Pregnant Women and Parents With Methamphetamine-Related Mental Disorders
    Petzold, Johannes
    Spreer, Maik
    Krueger, Maria
    Sauer, Cathrin
    Kirchner, Tobias
    Hahn, Susanna
    Zimmermann, Ulrich S.
    Pilhatsch, Maximilian
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [7] Crystalline methamphetamine use and methamphetamine-related harms in Australia
    Degenhardt, Louisa
    Sara, Grant
    McKetin, Rebecca
    Roxburgh, Amanda
    Dobbins, Timothy
    Farrell, Michael
    Burns, Lucinda
    Hall, Wayne D.
    DRUG AND ALCOHOL REVIEW, 2017, 36 (02) : 160 - 170
  • [8] Methamphetamine-related stroke: Four cases
    Perez, JA
    Arsura, EL
    Strategos, S
    JOURNAL OF EMERGENCY MEDICINE, 1999, 17 (03): : 469 - 471
  • [9] Mechanisms underlying methamphetamine-related dental disease
    Clague, Jason
    Belin, Thomas R.
    Shetty, Vivek
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2017, 148 (06): : 377 - 386
  • [10] Evidence-Based Guidelines for the Pharmacological Management of Acute Methamphetamine-Related Disorders and Toxicity
    Wodarz, Norbert
    Krampe-Scheidler, Anne
    Christ, Michael
    Fleischmann, Heribert
    Looser, Winfried
    Schoett, Katharina
    Vilsmeier, Frank
    Bothe, Lydia
    Schaefer, Corinna
    Gouzoulis-Mayfrank, Euphrosyne
    PHARMACOPSYCHIATRY, 2017, 50 (03) : 87 - 95